Leading Health Groups Push Congress for $20B to Close the Women's Health Research Gap

Three major women's health organizations have unveiled a national framework calling on Congress to invest $20 billion over the next decade to fix long-standing gaps in women's health research, care, and workforce — a gap that helps explain why conditions like chronic UTI, interstitial cystitis, and bacterial vaginosis remain understudied and under-treated.

In this article:

• What was announced
• Where the money would go
• Why the gap exists
• Why this matters for chronic UTI/IC/BV patients

What Was Announced

On July 15, 2026, the American College of Obstetricians & Gynecologists (ACOG), the Society for Women's Health Research (SWHR), and the Women First Research Coalition (WFRC) launched the National Strategy to Close the Women's Health Gap. The framework has been endorsed by more than 35 organizations, including the Endocrine Society and groups spanning cardiology, neurology, and patient advocacy. It builds on the 1993 NIH Revitalization Act, which first required women's inclusion in NIH-funded clinical research, but argues that significant gaps remain in research, clinical care, and how findings actually reach patients.

Where the Money Would Go

The plan asks Congress for $20 billion over 10 years across five priorities: research and innovation, modernized policy, data infrastructure, clinical and research workforce support, and public education. The two largest line items — $7 billion each — would go toward research and innovation and toward strengthening the women's health workforce, including loan repayment programs and new Women's Health Centers of Excellence. A smaller $1 billion piece would fund public health literacy campaigns.

Why the Gap Exists

The organizations point to a stark funding imbalance: women make up more than half the U.S. population, yet women's health research receives less than 10% of total NIH funding. The strategy's organizing principle is "sex as a biological variable" — the idea that sex-based differences affect far more than reproductive health alone, extending into cardiovascular disease, autoimmune conditions, and neurological disorders.

Why This Matters

Chronic UTI, interstitial cystitis, and bacterial vaginosis are textbook examples of the pattern this strategy is trying to address: common conditions that disproportionately affect women, lack robust diagnostic tools, and have historically attracted limited dedicated research funding. This is a policy framework, not a funded program — nothing changes for patients immediately, and it will need congressional action to move forward. But the scale of organizational backing suggests sustained pressure to redirect research dollars toward the kinds of conditions that don't get flashy headlines but affect millions of daily lives.

Conclusion

The National Strategy is a long-term advocacy push, not a done deal. Still, for patients managing chronic, poorly understood gynecologic and urologic conditions, it's a signal that the research funding conversation in Washington is shifting — worth watching as it moves through Congress.

Sources

• ACOG, "Leading Women's Health Organizations Launch National Strategy to Close the Women's Health Gap" (July 2026): acog.org
• Contemporary OB/GYN, "National strategy calls for $20B investment to close women's health gap" (July 2026): contemporaryobgyn.net
• Forbes, "The $20 Billion Question—What Counts As Women's Health?" (July 16, 2026): forbes.com